Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

PneumoRecs VaxAdvisor Screenshots

iPad

iPhone

About PneumoRecs VaxAdvisor

This is the PneumoRecs VaxAdvisor App created by the Centers for Disease Control and Prevention (CDC) in collaboration with the Georgia Tech Research Institute. PneumoRecs VaxAdvisor provides patient-specific pneumococcal vaccination guidance consistent with the pneumococcal vaccination recommendations of the Advisory Committee on Immunization Practices. Vaccination providers enter a patient’s age and respond to prompts about the patient’s pneumococcal vaccination history and underlying medical conditions. The app then displays patient-specific pneumococcal vaccination recommendations consistent with the recommended U.S. immunization schedule.

What's New in the Latest Version 1.9

Last updated on Oct 12, 2023

Old Versions

This updated version of the app ensures that all content aligns with the latest published recommendations.

Version History

1.9

Oct 12, 2023

This updated version of the app ensures that all content aligns with the latest published recommendations.

1.8

Sep 20, 2023

Updated guidance for using PCV20 in children is now included.

1.7

Mar 29, 2023

Minor updates to clarify recommendations

1.6

Feb 8, 2023

This update incorporates the latest changes to the adult pneumococcal vaccination schedule, including recommendations for those who previously received PCV13.

1.5

Sep 15, 2022

This update incorporates the option of administering PCV15 to pediatric patients.

1.4

Jul 19, 2022

This update incorporates questions about prior PCV15 or PCV20 receipt among adults.

1.3

May 25, 2022

Streamlined process for entering a patient’s age, and minor text edits to questions about history of pneumococcal vaccination.

1.2

Apr 15, 2022

Updates have been made to include a selection for previous PCV13 vaccination among patients 19–64 years of age with chronic conditions.